![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Sullivan Ryan J Pantanowitz Liron
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.14, Iss.12, 2010-12, pp. : 1355-1366
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Dermatologic Surgery, Vol. 22, Iss. 3, 1996-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Imatinib: Kaposi's sarcoma: case report
Reactions Weekly, Vol. 1, Iss. 1295-1296, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab: Kaposi's sarcoma: case report
Reactions Weekly, Vol. 1, Iss. 1315, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Endocannabinoids New Targets for Drug Development
Current Pharmaceutical Design, Vol. 6, Iss. 13, 2000-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drug Discovery: Methods for Identifying New Drug Targets
Drug Design Reviews - Online, Vol. 2, Iss. 1, 2005-02 ,pp. :